![](/images/general/no_picture/200_user.png)
Hoa T Le
Examiner (ID: 13075, Phone: (571)272-1511 , Office: P/1788 )
Most Active Art Unit | 1788 |
Art Unit(s) | 1794, 1787, 1316, 2899, 1773, 1788, 1509, 1709 |
Total Applications | 2557 |
Issued Applications | 1900 |
Pending Applications | 185 |
Abandoned Applications | 471 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18955157
[patent_doc_number] => 20240043484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => REGENERATIVE POLYPEPTIDES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/471220
[patent_app_country] => US
[patent_app_date] => 2023-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30823
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18471220
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/471220 | REGENERATIVE POLYPEPTIDES AND USES THEREOF | Sep 19, 2023 | Pending |
Array
(
[id] => 18921282
[patent_doc_number] => 20240024286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => MATERIALS AND METHODS FOR IMPROVING GASTROINTESTINAL FUNCTION
[patent_app_type] => utility
[patent_app_number] => 18/363448
[patent_app_country] => US
[patent_app_date] => 2023-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22506
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18363448
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/363448 | MATERIALS AND METHODS FOR IMPROVING GASTROINTESTINAL FUNCTION | Jul 31, 2023 | Pending |
Array
(
[id] => 18737973
[patent_doc_number] => 20230346875
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => COMPOSITIONS AND METHODS FOR IMPROVING BRUISING AND REJUVENATING SKIN
[patent_app_type] => utility
[patent_app_number] => 18/212119
[patent_app_country] => US
[patent_app_date] => 2023-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34158
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18212119
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/212119 | COMPOSITIONS AND METHODS FOR IMPROVING BRUISING AND REJUVENATING SKIN | Jun 19, 2023 | Pending |
Array
(
[id] => 18830837
[patent_doc_number] => 20230399362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => INTERLEUKIN-13 BINDING CYCLIC OLIGOPEPTIDES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/334309
[patent_app_country] => US
[patent_app_date] => 2023-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16019
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18334309
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/334309 | INTERLEUKIN-13 BINDING CYCLIC OLIGOPEPTIDES AND METHODS OF USE THEREOF | Jun 12, 2023 | Pending |
Array
(
[id] => 18709189
[patent_doc_number] => 20230331801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => IL-2R-BETA-GAMMA BINDING COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/321472
[patent_app_country] => US
[patent_app_date] => 2023-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75627
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 226
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18321472
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/321472 | IL-2R-BETA-GAMMA BINDING COMPOUNDS | May 21, 2023 | Pending |
Array
(
[id] => 18893794
[patent_doc_number] => 20240009279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => TREATMENT OF PATIENTS WITH SEVERE VON WILLEBRAND DISEASE UNDERGOING ELECTIVE SURGERY BY ADMINISTRATION OF RECOMBINANT VWF
[patent_app_type] => utility
[patent_app_number] => 18/316988
[patent_app_country] => US
[patent_app_date] => 2023-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41769
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18316988
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/316988 | TREATMENT OF PATIENTS WITH SEVERE VON WILLEBRAND DISEASE UNDERGOING ELECTIVE SURGERY BY ADMINISTRATION OF RECOMBINANT VWF | May 11, 2023 | Pending |
Array
(
[id] => 18656223
[patent_doc_number] => 20230302108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => ALK POLYPEPTIDES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/176013
[patent_app_country] => US
[patent_app_date] => 2023-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 83711
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18176013
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/176013 | ALK POLYPEPTIDES AND METHODS OF USE THEREOF | Feb 27, 2023 | Pending |
Array
(
[id] => 18893635
[patent_doc_number] => 20240009120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => Ocular Compositions and Methods Thereof
[patent_app_type] => utility
[patent_app_number] => 18/112468
[patent_app_country] => US
[patent_app_date] => 2023-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9663
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18112468
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/112468 | Ocular Compositions and Methods Thereof | Feb 20, 2023 | |
Array
(
[id] => 18707600
[patent_doc_number] => 20230330177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => USE OF PAYCS IN REGULATION OF INTESTINAL FLORA, METABOLITES, AND BRAIN NEUROTRANSMITTERS
[patent_app_type] => utility
[patent_app_number] => 18/170163
[patent_app_country] => US
[patent_app_date] => 2023-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3894
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18170163
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/170163 | USE OF PAYCS IN REGULATION OF INTESTINAL FLORA, METABOLITES, AND BRAIN NEUROTRANSMITTERS | Feb 15, 2023 | Pending |
Array
(
[id] => 18434239
[patent_doc_number] => 20230181533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => FORMULATIONS WITH REDUCED OXIDATION
[patent_app_type] => utility
[patent_app_number] => 18/105752
[patent_app_country] => US
[patent_app_date] => 2023-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28617
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18105752
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/105752 | FORMULATIONS WITH REDUCED OXIDATION | Feb 2, 2023 | Pending |
Array
(
[id] => 18552134
[patent_doc_number] => 20230250143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => NOVEL MUTANT BACTERIORHODOPSIN-LIKE-CHANNELRHODOPSIN ION CHANNEL
[patent_app_type] => utility
[patent_app_number] => 18/164297
[patent_app_country] => US
[patent_app_date] => 2023-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23380
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18164297
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/164297 | NOVEL MUTANT BACTERIORHODOPSIN-LIKE-CHANNELRHODOPSIN ION CHANNEL | Feb 2, 2023 | Pending |
Array
(
[id] => 18675090
[patent_doc_number] => 20230312663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => Regenerative Polypeptides and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 18/163210
[patent_app_country] => US
[patent_app_date] => 2023-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30497
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18163210
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/163210 | Regenerative Polypeptides and Uses Thereof | Jan 31, 2023 | Pending |
Array
(
[id] => 18404578
[patent_doc_number] => 20230165929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => TREATMENT OF RESPIRATORY TRACT DISEASES AND INFECTIONS WITH ASCORBIC ACID COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/160513
[patent_app_country] => US
[patent_app_date] => 2023-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23010
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -96
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18160513
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/160513 | TREATMENT OF RESPIRATORY TRACT DISEASES AND INFECTIONS WITH ASCORBIC ACID COMPOSITIONS | Jan 26, 2023 | Pending |
Array
(
[id] => 18405805
[patent_doc_number] => 20230167156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => SOLID STATE FORMS OF VOCLOSPORIN
[patent_app_type] => utility
[patent_app_number] => 18/100032
[patent_app_country] => US
[patent_app_date] => 2023-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6296
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18100032
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/100032 | SOLID STATE FORMS OF VOCLOSPORIN | Jan 22, 2023 | Pending |
Array
(
[id] => 18725818
[patent_doc_number] => 20230340039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => NPY2 RECEPTOR AGONISTS
[patent_app_type] => utility
[patent_app_number] => 18/068641
[patent_app_country] => US
[patent_app_date] => 2022-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23786
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18068641
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/068641 | NPY2 RECEPTOR AGONISTS | Dec 19, 2022 | Pending |
Array
(
[id] => 18770830
[patent_doc_number] => 20230365629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => SYNTHESIS OF ECHINOCANDIN ANTIFUNGAL AGENT
[patent_app_type] => utility
[patent_app_number] => 18/077902
[patent_app_country] => US
[patent_app_date] => 2022-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8369
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18077902
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/077902 | SYNTHESIS OF ECHINOCANDIN ANTIFUNGAL AGENT | Dec 7, 2022 | |
Array
(
[id] => 18752314
[patent_doc_number] => 20230355537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => PROMOTING TRAINED IMMUNITY WITH THERAPEUTIC NANOBIOLOGIC COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/076759
[patent_app_country] => US
[patent_app_date] => 2022-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19157
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18076759
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/076759 | PROMOTING TRAINED IMMUNITY WITH THERAPEUTIC NANOBIOLOGIC COMPOSITIONS | Dec 6, 2022 | Pending |
Array
(
[id] => 19274433
[patent_doc_number] => 12024544
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-02
[patent_title] => CCN3 and CCN3 peptides and analogs thereof for therapeutic use
[patent_app_type] => utility
[patent_app_number] => 17/991219
[patent_app_country] => US
[patent_app_date] => 2022-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 53
[patent_no_of_words] => 14742
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17991219
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/991219 | CCN3 AND CCN3 PEPTIDES AND ANALOGS THEREOF FOR THERAPEUTIC USE | Nov 20, 2022 | Pending |
Array
(
[id] => 18657682
[patent_doc_number] => 20230303626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => MACROCYCLIC POLYPEPTIDES
[patent_app_type] => utility
[patent_app_number] => 18/054261
[patent_app_country] => US
[patent_app_date] => 2022-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10920
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18054261
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/054261 | MACROCYCLIC POLYPEPTIDES | Nov 9, 2022 | |
Array
(
[id] => 18673092
[patent_doc_number] => 20230310566
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => CDKN2A COMPANION DIAGNOSTIC FOR BLADDER CANCER INTERFERON THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/965739
[patent_app_country] => US
[patent_app_date] => 2022-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4577
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17965739
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/965739 | CDKN2A COMPANION DIAGNOSTIC FOR BLADDER CANCER INTERFERON THERAPY | Oct 12, 2022 | Pending |